Planned
There are currently no planned studies in our center.
Ongoing
There are currently no ongoing studies in our center.
Closed
I3Y-MC-JPBO
A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor positive breast cancer and melanoma
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02308020
CHECKMATE 848 CA209-848
A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03668119
CREATE EORTC 90101
Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT01524926